Online citations, reference lists, and bibliographies.
← Back to Search

Protein Release From Polyphosphazene Matrices.

Payne, Andrianov
Published 1998 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Polyphosphazenes have been exploited as carriers for protein delivery due to versatility of molecular structures and sophisticated spectrum of chemical and physical properties. Ease of structural manipulations for this class of organometallic polymers allows efficient control over physico-chemical parameters of polyphosphazenes including their biodegradability and matrix permeability. Some polyphosphazenes offer additional advantages as protein delivery vehicles since microencapsulation of substrates in these systems can be achieved under remarkably mild physiological conditions. Because of these properties polyphosphazenes have tremendous potential as matrices for protein release as shown by studies both in vitro and in vivo.
This paper references
10.1016/0168-3659(95)00193-X
Degradable phosphazene-crosslinked hydrogels
A. Grosse-Sommer (1996)
10.1021/ma60058a020
Synthesis of Poly[(amino acid alkyl ester)phosphazenes]
H. Allcock (1977)
10.1021/CR00085A005
Poly(alkyl/arylphosphazenes) and their precursors
R. Neilson (1988)
10.1128/IAI.59.9.2978-2986.1991
Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.
J. Eldridge (1991)
10.1021/MA00030A008
Synthesis of poly(dichlorophosphazenes) from Cl3P:NP(O)Cl2. 1. Kinetics and reaction mechanism
G. D'halluin (1992)
10.1021/MA951129+
Lower Critical Solubility Temperature Study of Alkyl Ether Based Polyphosphazenes
H. Allcock (1996)
10.1016/0168-3659(95)00136-0
Controlled macromolecule release from poly(phosphazene) matrices
S. M. Ibim (1996)
10.1016/0168-3659(91)90143-2
Development of injectable antitumor microspheres based on polyphosphazene
J. H. Goedemoed (1991)
10.1201/9781003067542-4
POLYPHOSPHAZENE HYDROGEL MICROSPHERES FOR PROTEIN DELIVERY
A. K. Andrianov (1996)
10.1002/APP.1994.070531203
Hydrolytic degradation of ionically cross‐linked polyphosphazene microspheres
A. K. Andrianov (1994)
10.21236/ada279695
Water-Soluble Polyphosphazenes and Their Hydrogels
H. Allcock (1994)
10.1201/9780429282287
Microcapsules and Nanoparticles in Medicine and Pharmacy
M. Donbrow (1991)
10.1021/MA00083A001
Poly[(amino acid ester)phosphazenes]: Synthesis, Crystallinity, and Hydrolytic Sensitivity in Solution and the Solid State
H. Allcock (1994)
10.1021/MA00092A038
Synthesis, Characterization, and Modification of Poly(organophosphazenes) with Both 2,2,2-Trifluoroethoxy and Phenoxy Side Groups
H. Allcock (1994)
10.1016/0142-9612(96)00073-7
Synthesis and characterization of pH-sensitive poly(organophosphazene) hydrogels.
H. Allcock (1996)
10.1016/0169-409x(93)90027-2
Biodegradable Hydrogels for Drug Delivery
K. R. Kamath (1993)
Polyphosphazenes as new biomedical and bioactive materials
H. Allcock (1990)
10.1038/NBT0591-468
A Novel Synthetic Method for Hybridoma Cell Encapsulation
M. Bañó (1991)
10.1007/978-3-642-74529-4_6
Biodegradable microspheres: vaccine delivery system for oral immunization.
J. Eldridge (1989)
10.1002/(SICI)1097-4628(19960620)60:12<2289::AID-APP28>3.0.CO;2-0
Characterization of poly[di(carboxylatophenoxy)‐phosphazene] by an aqueous gel permeation chromatography
A. K. Andrianov (1996)
10.1016/0168-3659(93)90058-D
Controlled release using ionotropic polyphosphazene hydrogels
A. K. Andrianov (1993)
10.1021/MA00191A015
Ionically cross-linkable polyphosphazene: poly(bis(carboxylatophenoxy) phosphazene) and its hydrogels and membranes
H. Allcock (1989)
10.1007/978-1-4615-1823-5_20
Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery.
L. G. Payne (1995)
10.1126/SCIENCE.2218494
New methods of drug delivery.
R. Langer (1990)
10.1021/MA00005A005
Poly(organophosphazenes) with oligopeptides as side groups : prospective biomaterials
H. Allcock (1991)
Xenobiotic polymers as vaccine vehicles.
L. G. Payne (1995)
10.1007/BF00696533
Preparation of inorganic and organometallic polymers with controlled structures
K. Matyjaszewski (1992)
10.1016/0142-9612(93)90235-T
Degradation of poly[bis(glycine ethyl ester)phosphazene] in aqueous media.
E. M. Ruiz (1993)
10.1021/ic00132a009
Hydrolysis pathways for aminophosphazenes
H. Allcock (1982)
10.1007/BF01058142
Degradation of poly[bis(ethylamino)phosphazene] in aqueous solution
Tetsuya Tanigami (1995)
10.1016/S0264-410X(97)00149-7
Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.
L. G. Payne (1998)
10.1021/MA960876J
“Living” Cationic Polymerization of Phosphoranimines as an Ambient Temperature Route to Polyphosphazenes with Controlled Molecular Weights
H. Allcock (1996)
10.1021/MA00160A003
Polyphosphazenes with etheric side groups: prospective biomedical and solid electrolyte polymers
H. Allcock (1986)
10.1016/0168-3659(93)90176-6
Degradable polyphosphazenes for biomedical applications
J. Crommen (1993)
10.1016/0142-9612(94)90205-4
Poly[(amino acid ester)phosphazenes] as substrates for the controlled release of small molecules.
H. Allcock (1994)
10.1002/JBM.820211006
Controlled release using a new bioerodible polyphosphazene matrix system.
C. Laurencin (1987)
10.1021/JA00177A074
Ionically crosslinkable polyphosphazene: a novel polymer for microencapsulation
S. Cohen (1990)
10.1016/0169-409X(93)90025-Y
PREPARATION, STRUCTURE AND DIFFUSIONAL BEHAVIOR OF HYDROGELS IN CONTROLLED RELEASE
N. Peppas (1993)
10.1016/0142-9612(88)90046-4
Hydrophilic polyphosphazenes as hydrogels: radiation cross-linking and hydrogel characteristics of poly[bis(methoxyethoxyethoxy)phosphazene].
H. Allcock (1988)



This paper is referenced by
Mechanical Properties of Poly (vinyl alcohol) Based Blends and Composites
Nazanin Afghan (2016)
10.1517/17425247.2.5.791
Microparticles for oral delivery of vaccines
G. Mutwiri (2005)
10.1016/S1381-5148(02)00081-0
Synthesis, characterization, in vitro degradation and cytotoxicity of poly[bis(ethyl 4-aminobutyro)phosphazene]
M. Gümüşderelioğlu (2002)
10.1007/S13369-019-03952-1
Synthesis, Characterization and Hydrolytic Degradation of p-Cresol-Substituted Polyphosphazenes
T. G. Shahzady (2019)
10.1002/jps.21493
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
S. Sharma (2009)
10.1016/B978-0-12-381422-7.10033-1
Chapter 33 – Synthetic Polymers
M. Hacker (2011)
10.1007/3-540-45734-8_3
Degradable polymer microspheres for controlled drug delivery
U. Edlund (2002)
10.1016/j.nano.2017.05.012
Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice.
K. Schulze (2017)
10.1002/JBM.A.30145
Formation of hydroxyapatite-polyphosphazene polymer composites at physiologic temperature.
Y. Greish (2006)
10.1016/J.POLYMER.2016.11.049
Interpolyelectrolyte complexes of lysozyme with short poly[di(carboxylatophenoxy)phosphazene]. Binding energetics and protein conformational stability
T. Burova (2017)
10.1016/S0169-409X(03)00039-5
Biodegradable polyphosphazenes for drug delivery applications.
S. Lakshmi (2003)
10.1002/APP.13449
Microencapsulation of capsaicin by the complex coacervation of gelatin, acacia and tannins
F. Xing (2004)
Vaccin contre la grippe, composition et procédés d'utilisation
Sylvie Alonso (2009)
10.1016/J.VACCINE.2006.10.011
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
G. Mutwiri (2007)
10.1002/MASY.200650313
Metal‐Containing Poly(Organophosphazenes)
P. Pertici (2006)
10.1007/B137240
Polymers as biomaterials for tissue engineering and controlled drug delivery.
L. Nair (2006)
10.1081/E-EBPPC-120050409
Drug Delivery Systems: Selection Criteria and Use
R. Semwal (2017)
10.1016/j.vaccine.2009.01.117
CpG oligonucleotide, host defense peptide and polyphosphazene act synergistically, inducing long-lasting, balanced immune responses in cattle.
J. Kovacs-Nolan (2009)
10.3724/SP.J.1105.2010.00125
PREPARATION OF POLYPHOSPHAZENE MICROPARTICLES VIA ELECTROSPRAY: PREPARATION OF POLYPHOSPHAZENE MICROPARTICLES VIA ELECTROSPRAY
Y. Zhou (2010)
10.1007/BF03218454
Design parameters of polymers for tissue engineering applications
K. Lee (2005)
10.1016/j.actbio.2009.12.012
Mechanical properties and osteocompatibility of novel biodegradable alanine based polyphosphazenes: Side group effects.
S. Sethuraman (2010)
10.1134/S0965545X0904004X
Unwinding of ι-carrageenan double helix upon complex formation with polyethylaminophosphazene hydrochloride
V. Grinberg (2009)
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Zahra Ghalanbor (2011)
10.1517/14712598.4.8.1203
Protein and peptide parenteral controlled delivery
R. Pawar (2004)
10.3109/1061186X.2010.523790
Nasal vaccine innovation
I. Jabbal‐Gill (2010)
10.1007/0-306-47932-X_1
Challenges in polymer therapeutics: state of the art and prospects of polymer drugs.
A. Kabanov (2003)
10.1016/S1367-5931(00)00227-1
Polymers in drug delivery.
O. Pillai (2001)
10.1021/la303860t
Ternary interpolyelectrolyte complexes insulin-poly(methylaminophosphazene)-dextran sulfate for oral delivery of insulin.
T. Burova (2013)
10.1051/VETRES:2006012
Mucosal delivery of vaccines in domestic animals.
V. Gerdts (2006)
10.1039/B926402G
Polyphosphazene polymers for tissue engineering: an analysis of material synthesis, characterization and applications
Meng Deng (2010)
10.1007/S10904-006-9065-4
Water-Soluble Polyphosphazenes for Biomedical Applications
A. K. Andrianov (2006)
10.1201/9781420025866.CH11
Polymeric Systems for Oral Protein and Peptide Delivery
R. Gemeinhart (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar